BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15622478)

  • 1. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
    Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
    J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis.
    Yagi Y; Andoh A; Ogawa A; Bamba S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2007 Oct; 11(5):331-6. PubMed ID: 17845392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
    Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Sasaki M; Obata H; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Jun; 9(3):270-6. PubMed ID: 15967005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
    Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
    Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10.
    Mandrekar P; Catalano D; White B; Szabo G
    Alcohol Clin Exp Res; 2006 Jan; 30(1):135-9. PubMed ID: 16433741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
    Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.
    Takeda Y; Hiraishi K; Takeda H; Shiobara N; Shibusawa H; Saniabadi AR; Adachi M; Kawata S
    Inflamm Res; 2003 Jun; 52(7):287-90. PubMed ID: 12861393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
    Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
    Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.
    Bouchelouche K; Alvarez S; Horn T; Nordling J; Bouchelouche P
    Urology; 2006 Jan; 67(1):214-9. PubMed ID: 16413378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
    Sawada K; Kusugami K; Suzuki Y; Bamba T; Munakata A; Hibi T; Shimoyama T
    Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K
    World J Gastroenterol; 2005 May; 11(20):3085-90. PubMed ID: 15918195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells.
    Hsiang CY; Wu SL; Cheng SE; Ho TY
    J Biomed Sci; 2005 Oct; 12(5):791-801. PubMed ID: 16132116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
    Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of interleukin-1b and tumor necrosis factor--a by peripheral blood human mononuclear cells in active and inactive stages of ulcerative colitis.
    Nikolopoulou V; Katsakoulis E; Tsiotos P; Thomopoulos K; Salsaa B; Zoumbos N
    Z Gastroenterol; 1995 Jan; 33(1):9-12. PubMed ID: 7886987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.